[1]
Sharaf Eldeen, D. and Abdelgawad, A. 2018. Gemcitabine and vinorelbine: treatment option in recurrent platinum – resistant ovarian cancer. European Journal of Oncology. 22, 3-4 (Mar. 2018), 131-137.